SCOTT COLEMAN: Open Payments
NPI 1649352139 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 5 payments from 3 companies in 2025. Trend: 2023 $494 · 2024 $112 · 2025 $387
Food & beverage: $221Education: $166
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $182 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Neurocrine BioSciences, Inc. | 1 | $94 |
Products named: COBENFY, INGREZZA.
Industry payments across ID — which companies pay providers there.
